Show simple item record

dc.creatorUS National Cancer Instituteen_GB
dc.date.accessioned2006-05-02T13:15:33Z
dc.date.available2006-05-02T13:15:33Z
dc.date.created2003-02-01en_GB
dc.date.issued2006-05-02T13:15:33Z
dc.identifierNSC283464en_GB
dc.identifier.urihttp://www.dspace.cam.ac.uk/handle/1810/158711
dc.format.extent11760 bytes
dc.format.extent9574 bytes
dc.format.mimetypechemical/x-cml
dc.format.mimetypechemical/x-cml
dc.language.isoen_GB
dc.publisherUnilever Center for Molecular Informatics, Cambridge Universityen_GB
dc.titleNSC283464en_GB
dc.title.alternativeL-lyxo-Hexopyranoside, 3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5, 12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-2,3, 6-trideoxy-3-(2,2,2-trifluoroacetamido)-, (1S,3S)- .alpha.- (8CI)en_GB
dc.title.alternativeL-lyxo-Hexopyranoside, 3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5, 12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3, 6-trideoxy-3-(2,2,2-trifluoroacetamido)-, (1S,3S)-.alpha.-en_GB
dc.title.alternativeN-Trifluoroacetyladriamycinen_GB
dc.title.alternative5,12-Naphthacenedione, 7,8,9, 10-tetrahydro-6,8, 11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3, 6-trideoxy-3-[(trifluoroacetyl)amino]-.alpha.-L-lyxo-hexopyranosyl ]oxy]-, (8S-cis)-en_GB
dc.typeChemical Structuresen_GB
dc.identifier.inchikeyRQIOYWADAKTIJC-PSDMCKKUSA-N
dc.identifier.inchiInChI=1S/C29H28F3NO12/c1-10-22(36)13(33-27(41)29(30,31)32)6-17(44-10)45-15-8-28(42,16(35)9-34)7-12-19(15)26(40)21-20(24(12)38)23(37)11-4-3-5-14(43-2)18(11)25(21)39/h3-5,10,13,15,17,22,34,36,38,40,42H,6-9H2,1-2H3,(H,33,41)/t10-,13+,15+,17+,22-,28+/m1/s1
dc.identifier.ichiC29H28F3NO12,1H3-23H-27H(41H)25H(33H-22(37)29(30,31)32)8H2-26H(44-23)45-24H-9H2-28(42H,13(34)7H2-38H)6H2-12-17(24)21(40H)16-15(20(12)39H)18(35)10-4H-3H-5H-11(43-2H3)14(10)19(16)36en_GB


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

  • WWMM
    The WorldWideMolecularMatrix, an Open collection of information on small molecules

Show simple item record